Cannabis greatly helped him in the last six months of his life, Hershkovitch says, which inspired him to take the plant seriously as a therapeutic. IMCI’s iCann platform has three different products, each with different qualities: The fast-acting version comes in the form of a pill placed under the tongue, which takes 5 to 10 minutes to act and lasts for up to two and a half hours; the long-lasting version is a tablet that adheres to the inside of the mouth, and while it takes up to 45 minutes to take effect, the benefits can last for as long as eight hours; the final version is a pill that is swallowed, which takes around 20 minutes to take effect and lasts for up to four hours. The Gan Yavne-based company was founded in 2018 after Hershkovitch’s business partner in a previous venture was diagnosed with stage four cancer of the stomach. Unlimited root room and good genetics can see a plant grow to three or four meters during the vegetative phase.

"We couldn’t see smoking as a solution," IMCI Pharmaceuticals CEO Alon Hershkovitz tells NoCamels. In fact, Hershkovitz explains, the company plans to provide the nanoparticles to pharmacies so that the pharmacist can create a "tailor-made solution" on the spot, according to the specific dosage prescribed by a physician. The three different therapies are all designed for people suffering from chronic ailments and pain, and Hershkovitz says they all complement one another to provide treatment options for website reference link people suffering from a range of disorders, including pain, colitis, Alzheimer’s and autism. Largely self-funded, IMCI began to develop its therapies - with some support from the government’s Israel Innovation Authority and an angel investor. And although the company primarily uses THC as its analgesic, the intoxicating qualities that are sought after by recreational users of cannabis are seen as a side effect that IMCI counters by carefully controlling the dosage in each treatment.

IMCI then uses a proprietary method to turn that substance into nanoparticles. What IMCI, which views itself as an R&D startup rather than a drug company, came up with was a way to create nanoparticles out of cannabis, which are then taken in one of three ways. "This is consistent with recent findings from the US that indicates medical cannabis use had a role in a nearly 25 per cent reduction in opioid overdose deaths - which is a really big deal given the crisis Canada faces with prescription opioid use," says Walsh, noting Canadians are amongst the highest users of opiate-based drugs. Cannabis has been long maligned as an addictive narcotic that could lead to serious health issues, but a UBC and University of Victoria study demonstrates that more information people are using cannabis as a substitute for prescription drugs and alcohol. Safety Council meetings are open to all OTA members.

It’s open every day of the week from 11 am to 8 pm. I’ve had to make cutbacks to do so, but it’s worth it. It’s a huge weight off people’s minds to not worry about police turning up at your door. It’s not that it’s not happening, Should you have virtually any queries concerning in which and also the way to use read more, you are able to e mail us in our web page. it is, but it’s still very limited in terms of access. Legal access to cannabis might affect the broader social costs related article to the use of both legal and illicit psychoactive substances, says Walsh. ’ll be able get access as a patient. GF: So you’re essentially a facilitator to help get the cannabis industry going there. Green Flower: What would you say your position is in the burgeoning Thai cannabis industry? Green Flower caught up with Chopaka to get her thoughts on the reality of medical cannabis in Thailand. That parenting isn’t something to get right-it’s something to live, moment by moment.